Dysregulated CD46 signals during the contracting phase prevent normal IFN‐γ shut‐down and the switch into normal Th1 contraction and contribute to disease pathology in RA and multiple sclerosis (MS) 15, 16. The gene discussed is CD46; the disease is rheumatoid arthritis.